icon-folder.gif   Conference Reports for NATAP  
 
  EASL 46th Annual Meeting
March 30th - April 3rd 2011
Berlin, Germany
Back grey_arrow_rt.gif
 
 
 
The Pharmacokinetic Interaction Between Methadone and the Investigational HCV Protease Inhibitor Telaprevir
 
 
  Reported by Jules Levin
46th Annual Meeting of the European Association for the Study of the Liver (The International Liver CongressTM 2011), Berlin, Germany, 30 March-3 April 2011
 
Rolf van Heeswijk,1 Ann Vandevoorde,1 Peter Verboven,2 Griet Boogaerts,1 Els De Paepe,1 Rodica van Solingen-Ristea,1 Varun Garg,3 Maria Beumont1 1Tibotec BVBA, Beerse, Belgium; 2Janssen Research and Development, Beerse, Belgium; 3Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif